| Analysis | Metabolite Name | Measured Value | Units | Genotype:FLOX | Intestinal Segment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 2096 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 3136 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 3541 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 5272 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 5518 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 5863 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 6064 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 8167 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 9226 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 10167 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 10663 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 20129 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 20196 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21382 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21935 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 22515 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 28184 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 29225 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 34898 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 36366 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 40674 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 42487 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 42966 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 43145 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 50891 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 51234 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 51951 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 58020 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 77074 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 80923 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 81404 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 88910 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 101885 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 103040 | Peak area | Illeum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 104686 | Peak area | Jejunum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 114108 | Peak area | Duodenum |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Duodenum | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Illeum | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Jejunum | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Duodenum | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Illeum | |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | Peak area | Jejunum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1055 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1111 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1192 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1201 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1304 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1378 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1407 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 1480 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 2109 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 2305 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 3058 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 4436 | Peak area | Duodenum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 5834 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 6548 | Peak area | Duodenum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Duodenum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Illeum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Jejunum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Duodenum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Illeum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Jejunum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 1036 | Peak area | Duodenum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 1293 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 1789 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 2077 | Peak area | Duodenum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 2297 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 2410 | Peak area | Duodenum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 2425 | Peak area | Duodenum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 2630 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 3259 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 4046 | Peak area | Illeum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 6344 | Peak area | Jejunum |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Duodenum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Illeum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Jejunum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Duodenum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Illeum | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Jejunum |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|